Biblio Discovery — Demo Discovery Service

3 hasil untuk "Mathiyalagan, Navin"

Menampilkan 1–3 · 0,96 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Tumor metabolism in pheochromocytomas: clinical and therapeutic implications

    Jeeyavudeen, Mohammad Sadiq; Mathiyalagan, Navin; Fernandez James, Cornelius dkk.

    Explor Target Antitumor Ther · 2024 · Inggris · PubMed Central

    Pheochromocytomas and paragangliomas (PPGLs) have emerged as one of the most common endocrine tumors. It epitomizes fascinating crossroads of genetic, metabolic, and endocrine oncology, providing a canvas to explore the molecular intricacies of tumor biology. Predominantly rooted in the aberration…

  2. Artikel Jurnal Teks lengkap

    Do Socio-Economic Determinants Influence DPYD Testing? A Real-World Study of 1478 Cancer Patients Receiving Fluoropyrimidine Chemotherapy

    Baraka, Bahaaeldin; Mathiyalagan, Navin; Al-Ani, Maryam dkk.

    Med Sci (Basel) · 2026 · Inggris · PubMed Central

    Background: The DPYD gene encodes dihydropyrimidine dehydrogenase (DPD), an enzyme essential for metabolising chemotherapeutic agents such as capecitabine, 5-fluorouracil (5-FU), and tegafur. Variants in this gene can increase the toxicity of these treatments. Methods: This study analysed data from…

  3. Artikel Jurnal Teks lengkap

    The Real-World Impact of PARP Inhibitor Maintenance Therapy in High Grade Serous Tubo-Ovarian and Peritoneal Cancers

    Al-Ani, Maryam; Baraka, Bahaaeldin; Mathiyalagan, Navin dkk.

    Cancers (Basel) · 2025 · Inggris · PubMed Central

    Background: Pivotal clinical trials have led to the routine clinical use of PARP inhibitor (PARPi) (olaparib, niraparib, or rucaparib) maintenance therapy in high-grade serous tubo-ovarian and peritoneal cancers. Whether various PARPis have comparable clinical impact in the real-world is an area of…